Brentuximab Vedotin with chemotherapy for stage III or IV Hodgkin’s Lymphoma

J M, Connors; Jurczak, W; D J, Straus; S M, Ansell; W S, Kim; Gallamini, A; Younes, A; Alekseev, S; Illès, A; Picardi, M; Lech-Maranda, E; Oki, Y; Feldman, T; Smolewski, P; K J, Savage; N L, Bartlett; Walewski, J; Chen, R; Ramchendren, R; P L, Zinzani; Cunningham, D; Rosta, A; N C, Josephson; Song, E; Sachs, J; Liu, R; H A, Jolin; Huebner, D; Radford, J; Santoro, A (member of ECHELON-1 Study)

Brentuximab Vedotin with chemotherapy for stage III or IV Hodgkin’s Lymphoma / Connors J M; Jurczak W; Straus D J; Ansell S M; Kim W S; Gallamini A; Younes A; Alekseev S; Illès A; Picardi M; Lech-Maranda E; Oki Y; Feldman T; Smolewski P; Savage K J; Bartlett N L; Walewski J; Chen R; Ramchendren R; Zinzani P L; Cunningham D; Rosta A; Josephson N C; Song E; Sachs J; Liu R; Jolin H A; Huebner D; Radford J; Santoro A; (member of ECHELON-1 Study). - In: NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 378:4(2018), pp. 331-344.

Titolo:	Brentuximab Vedotin with chemotherapy for stage III or IV Hodgkin’s Lymphoma
Autori:	Connors J M Jurczak W Straus D J Ansell S M Kim W S Gallamini A Younes A Alekseev S Illès A Picardi M Lech-Maranda E Oki Y Feldman T Smolewski P Savage K J Bartlett N L Walewski J Chen R Ramchendren R Zinzani P L Cunningham D Rosta A Josephson N C Song E Sachs J Liu R Jolin H A Huebner D Radford J Santoro A (member of ECHELON-1 Study) mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2018
Rivista:	NEW ENGLAND JOURNAL OF MEDICINE
Handle:	http://hdl.handle.net/11699/7302
Appare nelle tipologie:	1.1 Articolo in rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11699/7302

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: